Ala. High Court To Reconsider Landmark Generic-Drug Ruling

Law360, New York (June 14, 2013, 6:37 PM EDT) -- The Alabama Supreme Court agreed Thursday to reconsider its January ruling that makers of brand-name drugs can be held liable for injuries caused by their generic counterparts, after Pfizer Inc. and another company called the decision an “extreme outlier position.”

The high court issued an order saying it would hold oral argument in the case in September. Pfizer, its subsidiary Wyeth Ltd. and Schwarz Pharma Inc. requested oral argument in a brief in February, arguing that the court had misunderstood the U.S. Supreme Court's Mensing decision. According...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.